List Of Exhibits
Exhibit 1 Cell and Gene Therapy Market in Europe: Segmentation
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 ATMPs in Development in Europe 2019
Exhibit 4 Impact of CMOs Offering Vector-Manufacturing Services
Exhibit 5 Cell & Gene Therapy Supply Chain
Exhibit 6 Impact of Robust Cell & Gene Therapy Pipeline
Exhibit 7 Impact of Increase in Strategic Acquisitions
Exhibit 8 Impact of Regulatory Support for Cell and Gene Therapy Market
Exhibit 9 Regulatory Pathway for Market Approval in Europe
Exhibit 10 Impact of Increasing Demand for CAR-T Therapy in Europe
Exhibit 11 Impact of Product Launches and Approvals
Exhibit 12 Impact of Covid-19 on Cell and Gene Therapy Products
Exhibit 13 Gene Therapy Trials Disrupted by Covid-19
Exhibit 14 Impact of Increasing Pricing Pressure for the Cell and Gene Therapy Products
Exhibit 15 Impact of Limitations of Gene Therapy Products
Exhibit 16 Cell & Gene Therapy Expenditure by European Companies 2019 ($ billion)
Exhibit 17 Recent Development & Commercialization of Cell &Gene Therapy Products in Europe
Exhibit 18 Cell & Gene Therapy Market in Europe by Product 2020 & 2026 (% share)
Exhibit 19 Cell & Gene Therapy Market in Europe by Application 2020 & 2026 (% share)
Exhibit 20 Cell & Gene Therapy Market in Europe by End-Users 2020 & 2026 Percentage Share Comparison
Exhibit 21 Cell & Gene Therapy Market in Europe by Geography: 2020 & 2026 (% share)
Exhibit 22 Cell & Gene Therapy Market in Europe 2020–2026 ($ million)
Exhibit 23 Five Forces Analysis 2020
Exhibit 24 Incremental Growth by Product 2020 & 2026
Exhibit 25 Europe Cell & Gene Therapy Market Segmentation by Product
Exhibit 26 Europe Cell & Gene Therapy Market by Product: Incremental Growth
Exhibit 27 Europe Cell & Gene Therapy Market by Product: Absolute Growth
Exhibit 28 CAR-T Cell Treated Patients Registered in EMBT Registry
Exhibit 29 Cell & Gene Therapy Market by Cell Therapy in Europe: Incremental Growth & Absolute Growth Comparison
Exhibit 30 Cell & Gene Therapy Market in Europe by Cell Therapy Product 2020–2026 ($ million)
Exhibit 31 Cell & Gene Therapy Market in Europe by Gene Therapy: Incremental Growth & Absolute Growth Comparison
Exhibit 32 Cell & Gene Therapy Market in Europe by Gene Therapy Product 2020–2026 ($ million)
Exhibit 33 Incremental Growth by Application 2020 & 2026
Exhibit 34 Europe Cell & Gene Therapy Market Segmentation by Application
Exhibit 35 Cell & Gene Therapy Market in Europe by Application: Incremental Growth
Exhibit 36 Europe Cell & Gene Therapy Market by Application: Absolute Growth
Exhibit 37 Europe Cell & Gene Therapy Market by Oncology: Incremental Growth & Absolute Growth Comparison
Exhibit 38 Europe Cell & Gene Therapy Market by Oncology 2020–2026 ($ million)
Exhibit 39 Europe Cell & Gene Therapy Market by Dermatology: Incremental Growth & Absolute Growth Comparison
Exhibit 40 Cell & Gene Therapy Market in Europe by Dermatology 2020–2026 ($ million)
Exhibit 41 Europe Cell & Gene Therapy Market by Musculoskeletal: Incremental Growth & Absolute Growth Comparison
Exhibit 42 Cell & Gene Therapy Market in Europe by Musculoskeletal 2020–2026 ($ million)
Exhibit 43 Cell & Gene Therapy Market in Europe by Others: Incremental Growth & Absolute Growth Comparison
Exhibit 44 Cell & Gene Therapy Market in Europe by Others 2020–2026 ($ million)
Exhibit 45 Incremental Growth by End-Users 2020 & 2026
Exhibit 46 Europe Cell & Gene Therapy Market Segmentation by End-user
Exhibit 47 Cell & Gene Therapy Market in Europe by End-User: Incremental Growth
Exhibit 48 Cell & Gene Therapy Market in Europe by End-User: Absolute Growth
Exhibit 49 Cell & Gene Therapy Market in Europe by Hospitals: Incremental Growth & Absolute Growth Comparison
Exhibit 50 Cell & Gene Therapy Market in Europe by Hospitals 2020–2026 ($ million)
Exhibit 51 Cell & Gene Therapy Market in Europe by Cancer Care Centers: Incremental Growth & Absolute Growth Comparison
Exhibit 52 Cell & Gene Therapy Market by Cancer Care Centers in Europe 2020–2026 ($ million)
Exhibit 53 Cell & Gene Therapy Market in Europe by Wound Care Centers: Incremental Growth & Absolute Growth Comparison
Exhibit 54 Cell & Gene Therapy Market by Wound Care Clinics in Europe 2020–2026 ($ million)
Exhibit 55 Cell & Gene Therapy Market in Europe by Others: Incremental Growth & Absolute Growth Comparison
Exhibit 56 Cell & Gene Therapy Market in Europe by Others 2020–2026 ($ million)
Exhibit 57 Incremental Growth by Geography 2020 & 2026
Exhibit 58 Europe Cell & Gene Therapy Market Segmentation by Geography
Exhibit 59 Cell & Gene Therapy Market in Europe by Geography: Incremental Growth
Exhibit 60 Cell & Gene Therapy Market in Europe by Geography: Absolute Growth
Exhibit 61 Global Audience of European Society of Cell & Gene Therapy
Exhibit 62 Main Contribution for European Society of Cell and Gene Therapy
Exhibit 63 Healthcare Expenditure of Western European Countries Relative to their GDP
Exhibit 64 Cell & Gene Therapy Market in Western Europe: Incremental Growth & Absolute Growth Comparison
Exhibit 65 Cell & Gene Therapy Market in Western Europe 2020–2026 ($ million)
Exhibit 66 Healthcare Expenditure of Eastern European Countries Relative to their GDP
Exhibit 67 Cell & Gene Therapy Market in Rest of Europe: Incremental Growth & Absolute Growth Comparison
Exhibit 68 Cell & Gene Therapy Market in Rest of Europe 2020–2026 ($ million)
Exhibit 69 Incremental Growth in Key Countries 2020 & 2026
Exhibit 70 Cell and Gene Therapy Market in Germany 2020–2026 ($ million)
Exhibit 71 Cell and Gene Therapy Market in France 2020–2026 ($ million)
Exhibit 72 Cell and Gene Therapy Market in UK 2020–2026 ($ million)
Exhibit 73 Cell and Gene Therapy Market in Italy 2020–2026 ($ million)
Exhibit 74 Cell and Gene Therapy Market in Spain 2020–2026 ($ million)
Exhibit 75 Cell and Gene Therapy Market in Switzerland 2020–2026 ($ million)
Exhibit 76 Cell and Gene Therapy Market in Netherlands 2020–2026 ($ million)
Exhibit 77 Novartis Revenue 2017-2019 ($ billion)
Exhibit 78 Novartis Segment Revenue Share 2019
Exhibit 79 Novartis: Regional Revenue Breakup 2019 (%)
Exhibit 80 Amgen Revenue 2019 - 2017 ($ billion)
Exhibit 81 Amgen: R&D Expenditure 2019 - 2017 ($ billion)
Exhibit 82 Gilead Sciences Revenue 2017–2019 ($ billion)
Exhibit 83 Gilead Sciences Research &Development Expenses 2017–2019 ($ billion)
Exhibit 84 Organogenesis Revenue 2018–2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Comparison of Conventional Therapy Versus ATMPs
Table 4 CMO Vector Manufacturers in Europe
Table 5 Gene Therapies in Significant Stages of Clinical Pipeline
Table 6 Recent Strategic Acquisitions in Europe Cell & Gene Therapy Market
Table 7 Product Approvals & Launches
Table 8 Major Cell & Gene Therapy Products Anticipated Near-Term Approvals in Europe
Table 9 Major Cell & Gene Therapy Products Anticipated Near-Term Approvals in Europe
Table 10 Major Cell & Gene Therapy Products Approved in Europe
Table 11 Gene Therapy Product Approved BY EMA
Table 12 Oncology Application Based Cell & Gene Therapy Products
Table 13 Oncology Application Based Cell & Gene Therapy Products
Table 14 Oncology Application Based Cell & Gene Therapy Products
Table 15 Other Application Based Cell & Gene Therapy Products
Table 16 Novartis: Major Product Offerings
Table 17 Spark Therapeutics: Major Product Offerings
Table 18 Amgen: Major Product Offerings
Table 19 Gilead Sciences: Major Product Offerings
Table 20 Organogenesis: Major Product Offerings
Table 21 APAC Biotech: Major Product Offerings
Table 22 AVITA MEDICAL: Major Product Offerings
Table 23 bluebird bio: Major Product Offerings
Table 24 CHIESI Farmaceutici: Major Product Offerings
Table 25 COLLPLANT: Major Product Offerings
Table 26 CO.DON: Major Product Offerings
Table 27 Human Stem Cell Institute: Major Product Offerings
Table 28 MEDIPOST: Major Product Offerings
Table 29 NUVASIVE: Major Product Offerings
Table 30 NIPRO: Major Product Offerings
Table 31 Orchard Therapeutics: Major Product Offerings
Table 32 RMS Regenerative Medical System: Major Product Offerings
Table 33 Orthocell: Major Product Offerings
Table 34 Osiris Therapeutics: Major Product Offerings
Table 35 Sibino GeneTech: Major Product Offerings
Table 36 Shanghai Sunway Biotech: Major Product Offerings
Table 37 Takeda Pharmaceutical Company: Major Product Offerings
Table 38 Terumo: Major Product Offerings
Table 39 Vericel: Major Product Offerings
Table 40 Cell & Gene Therapy Market by Geography 2020−2026 ($ million)
Table 41 Cell& Gene Therapy Market by Geography 2020−2026 (%)
Table 42 Cell & Gene Therapy Market by Product 2020−2026 ($ million)
Table 43 Cell& Gene Therapy Market by Product 2020−2026 (%)
Table 44 Cell & Gene Therapy Market by End-User 2020−2026 ($ million)
Table 45 Cell& Gene Therapy Market by End-User 2020−2026 (%)
Table 46 Cell & Gene Therapy Market by Application 2020−2026 ($ million)
Table 47 Cell& Gene Therapy Market by Application 2020−2026 (%)